Source: http://delcode.delaware.gov/title16/c009b/index.shtml
Timestamp: 2018-09-26 05:52:41
Document Index: 419385630

Matched Legal Cases: ['§ 901', '§ 902', '§ 903', '§ 904', '§ 905', '§ 906', '§ 901', '§ 902', '§ 902', '§ 902', '§ 714', '§ 902', '§ 902', '§ 903', '§ 903', '§ 905', '§ 903', '§ 908', '§ 904', '§ 906', '§ 905', '§ 903', '§ 906']

TITLE 16 - CHAPTER 9B. INFANTS WITH PRENATAL SUBSTANCE EXPOSURE
§ 901B § 902B § 903B § 904B § 905B § 906B
CHAPTER 9B. INFANTS WITH PRENATAL SUBSTANCE EXPOSURE
§ 901B Purpose.
(1) Requires that notifications of infants with prenatal substance exposure be made to the Division by the health-care provider involved in the delivery or care of the infant.
(2) Requires a coordinated, service-integrated response by various agencies in this State's health and child welfare systems to work together to ensure the safety and well-being of infants with prenatal substance exposure by developing, implementing, and monitoring a Plan of Safe Care that addresses the health and substance use treatment needs of the infant and affected family or caregiver.
§ 902B Definitions.
(1) "Division" is as defined in § 902 of this title.
(2) "Family assessment and services" is as defined in § 902 of this title.
(3) "Health-care provider" is as defined in § 714 of this title.
(4) "Infant with prenatal substance exposure" means a child not more than 1 year of age who is born with and identified as being affected by substance abuse or withdrawal symptoms or a fetal alcohol spectrum disorder. The health-care provider involved in the delivery or care of the infant shall determine whether the infant is affected by the substance exposure.
(5) "Internal information system" is as defined in § 902 of this title.
(6) "Investigation Coordinator" is as defined in § 902 of this title.
(7) "Plan of Safe Care" or "Plan" means a written or electronic plan to ensure the safety and well-being of an infant with prenatal substance exposure following the release from the care of a health-care provider by addressing the health and substance use treatment needs of the infant and affected family or caregiver, and monitoring these plans to ensure appropriate referrals are made and services are delivered to the infant and affected family or caregiver. The monitoring of these plans may be time limited based upon the circumstances of each case.
(8) "Substance abuse" means the chronic, habitual, regular, or recurrent use of alcohol, inhalants, or controlled substances as identified in Chapter 47 of this title.
(9) "Withdrawal symptoms" means a group of behavioral and physiological features in the infant that follow the abrupt discontinuation of a drug that has the capability of producing physical dependence. Withdrawal symptoms resulting exclusively from a prescription drug used by the mother or administered to the infant under the care of a prescribing medical professional, in compliance with the directions for the administration of the prescription as directed by the prescribing medical professional, its compliance and administration verified by the health-care provider involved in the delivery or care of the infant, and no other risk factors to the infant are present, is not included in the definition and does not warrant a notification to the Division under § 903B of this title.
§ 903B Notification to Division; immunity from liability.
(a) The health-care provider who is involved in the delivery or care of an infant with prenatal substance exposure shall make a notification to the Division by contacting the Division report line as identified in § 905 of this title.
(b) When 2 or more persons who are required to make a notification have joint knowledge of an infant with prenatal substance exposure, the telephone notification may be made by 1 person with joint knowledge who was selected by mutual agreement of those persons involved. The notification must include all persons with joint knowledge of an infant with prenatal substance exposure at the time the notification is made. Any person who has knowledge that the individual who was originally designated to make the notification has failed to do so, shall immediately make a notification.
(c) A notification made under this section is not to be construed to constitute a report of child abuse or neglect under § 903 of this title, unless risk factors are present that would jeopardize the safety and well-being of the infant.
(d) The immunity provisions under § 908 of this title will also apply to this chapter.
§ 904B Notification information.
(a) Upon receipt of a notification of an infant with prenatal substance exposure, the Division shall enter it into the Division's internal information system.
(b) Upon receipt of a notification of an infant with prenatal substance exposure, the Division shall notify the office of the Investigation Coordinator of the notification in sufficient detail to permit the Investigation Coordinator to undertake its duties as specified in § 906 of this title.
§ 905B State response to notifications of infants with prenatal substance exposure.
(a) In implementing the Division's role in protecting the safety and well-being of infants with prenatal substance exposure, upon receipt of a notification under § 903B of this title, the Division shall do all of the following:
(e) In implementing the Investigation Coordinator's role in ensuring the safety and well-being of infants with prenatal substance exposure, the Investigation Coordinator, or the Investigation Coordinator's staff, shall have electronic access and the authority to track within the Department's internal information system each notification of an infant with prenatal substance exposure.
§ 906B Data and reports.